Vigabatrin Trials and Dose Recommendations

J Gordon Millichap

doi:10.15844/pedneurbriefs-26-1-4

Vigabatrin Trials and Dose Recommendations

Pediatric Neurology Briefs

Volume 26 (2012): Issue 1

By: J Gordon Millichap

Open Access

|Jan 2012

Abstract

Major, well-controlled trials of Vigabatrin for infantile spasms in Europe, Canada, and the Unites States are reviewed, including dose recommendations.

References

Carmant L Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States, and recommendations for dosing Acta Neurol Scand 2011 Dec 124 Suppl 192 36 47 10.1111/j.1600-0404.2011.01599.x 22061179
Open DOI Search in Google Scholar Back to article
Pellock JM Balancing clinical benefits of vigabatrin with its associated risk of vision loss Acta Neurol Scand 2011 124 Suppl 192 83 91 10.1111/j.1600-0404.2011.01603.x 22061183
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-26-1-4 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 4 - 5

Published on: Jan 1, 2012

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Vigabatrin,

Hormonal Treatment,

Peripheral Visual Field Defects

© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 26 (2012): Issue 1